-Agreement Provides Flexible Funding on Path to NDA Submission for PAX-101- TARRYTOWN, NY - November 17, 2022 - PaxMedica, Inc. (Nasdaq: PXMD), a clinical stage biopharmaceutical company focusing on the development of novel anti-purinergic drug therapies (“APT”) for the treatment of disorders with intractable neurologic symptoms, today announced that the… Read More..

Gross Profit Increases over 7-fold, Gross Margin Expands from 28.7% to 49.0% Hauppauge, NY, Nov. 14, 2022 (GLOBE NEWSWIRE) -- AmpliTech Group, Inc (Nasdaq: AMPG), a designer, developer, and manufacturer of state-of-the-art signal-processing components for satellite, 5G, and other communications networks and a worldwide distributor of packages and lids for integrated circuit… Read More..

Hauppauge, NY, Nov. 08, 2022 (GLOBE NEWSWIRE) -- AmpliTech Group, Inc. (Nasdaq: AMPG), a designer, developer, and manufacturer of state-of-the-art signal-processing components for satellite, 5G, and other communications networks and a worldwide distributor of packages and lids for integrated circuit assembly, and designer of complete 5G/6G systems, today announced that it will… Read More..